The ICP-MS system is required to replace the currently outdated FDA laboratory ICP-MS system. The new system is a critical need for FDA/sffl/NAB to fulfill its overall mission of optimal…

Ended Awarded Last action

Contract number
75F40121F80437
Awardee
Awarding agency
Obligated
$246,011

Award facts

Contract value 100% obligated
$246,010.90 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Atlanta, GA 30309, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · To update the mailing and remit to addresses and duns number $0
Original award $246,011

About this award

The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $246,010.90 firm-fixed-price delivery order to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc., to replace the FDA's outdated Inductively Coupled Plasma Mass Spectrometry (ICP-MS) system. This new ICP-MS system is a critical need for the FDA's Southeast Food and Feed Laboratory National Analytical Branch (FDA/SFFL/NAB) to improve its capability and readiness to monitor food and feed samples. The contract is not set-aside and was awarded under the General Services Administration's (GSA) Multiple Award Schedule (MAS) contract vehicle on September 22, 2021, with a completion date of December 6, 2022. Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, and has provided various analytical instruments, equipment, and services to support federal agencies' research and laboratory operations.

Description

The ICP-MS system is required to replace the currently outdated FDA laboratory ICP-MS system. The new system is a critical need for FDA/sffl/NAB to fulfill its overall mission of optimal preparedness to improve capability and readiness to monitor the

Quick answers

Who was awarded contract 75F40121F80437?

75F40121F80437 was awarded to Agilent Technologies Inc. by Food and Drug Administration (Department of Health and Human Services) on September 22, 2021.

How much is contract 75F40121F80437 worth?

The government has obligated $246,011 on 75F40121F80437.

Is contract 75F40121F80437 an order under another contract?

Yes. 75F40121F80437 is a delivery order under GS07F0564X, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75F40121F80437 competed?

The extent of competition for 75F40121F80437 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award